Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

3,498 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Recombinant HIV-1 Pr55gag virus-like particles: potent stimulators of innate and acquired immune responses.
Deml L, Speth C, Dierich MP, Wolf H, Wagner R. Deml L, et al. Among authors: wagner r. Mol Immunol. 2005 Feb;42(2):259-77. doi: 10.1016/j.molimm.2004.06.028. Mol Immunol. 2005. PMID: 15488613 Review.
Studies on processing, particle formation, and immunogenicity of the HIV-1 gag gene product: a possible component of a HIV vaccine.
Wagner R, Fliessbach H, Wanner G, Motz M, Niedrig M, Deby G, von Brunn A, Wolf H. Wagner R, et al. Arch Virol. 1992;127(1-4):117-37. doi: 10.1007/BF01309579. Arch Virol. 1992. PMID: 1456888
Priming of class I-restricted cytotoxic T lymphocytes by vaccination with recombinant protein antigens.
Schirmbeck R, Deml L, Melber K, Wolf H, Wagner R, Reimann J. Schirmbeck R, et al. Among authors: wagner r. Vaccine. 1995 Jun;13(9):857-65. doi: 10.1016/0264-410x(94)00038-o. Vaccine. 1995. PMID: 7483809
Assembly and extracellular release of chimeric HIV-1 Pr55gag retrovirus-like particles.
Wagner R, Deml L, Fliessbach H, Wanner G, Wolf H. Wagner R, et al. Virology. 1994 Apr;200(1):162-75. doi: 10.1006/viro.1994.1175. Virology. 1994. PMID: 7510434
Induction of cytolytic T lymphocytes directed towards the V3 loop of the human immunodeficiency virus type 1 external glycoprotein gp120 by p55gag/V3 chimeric vaccinia viruses.
Wagner R, Böltz T, Deml L, Modrow S, Wolf H. Wagner R, et al. J Gen Virol. 1993 Jul;74 ( Pt 7):1261-9. doi: 10.1099/0022-1317-74-7-1261. J Gen Virol. 1993. PMID: 7687647
Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB).
Osterrieder N, Wagner R, Brandmüller C, Schmidt P, Wolf H, Kaaden OR. Osterrieder N, et al. Among authors: wagner r. Virology. 1995 Apr 20;208(2):500-10. doi: 10.1006/viro.1995.1181. Virology. 1995. PMID: 7747423
Induction of a MHC class I-restricted, CD8 positive cytolytic T-cell response by chimeric HIV-1 virus-like particles in vivo: implications on HIV vaccine development.
Wagner R, Deml L, Schirmbeck R, Reimann J, Wolf H. Wagner R, et al. Behring Inst Mitt. 1994 Dec;(95):23-34. Behring Inst Mitt. 1994. PMID: 7755506 Review.
Polyvalent, recombinant HIV-1 virus-like particles: novel HIV-1 vaccine strategies.
Wagner R, Deml L, Wolf H. Wagner R, et al. Antibiot Chemother (1971). 1994;46:48-61. doi: 10.1159/000423633. Antibiot Chemother (1971). 1994. PMID: 7826039 Review. No abstract available.
The gag proteins of human immunodeficiency virus type 1: mechanisms of virus assembly and possibilities for interference.
Modrow S, Kattenbeck B, von Poblotzki A, Niedrig M, Wagner R, Wolf H. Modrow S, et al. Among authors: wagner r. Med Microbiol Immunol. 1994 Sep;183(4):177-94. doi: 10.1007/BF00194171. Med Microbiol Immunol. 1994. PMID: 7845316 Review. No abstract available.
Identification of a region in the Pr55gag-polyprotein essential for HIV-1 particle formation.
von Poblotzki A, Wagner R, Niedrig M, Wanner G, Wolf H, Modrow S. von Poblotzki A, et al. Among authors: wagner r. Virology. 1993 Apr;193(2):981-5. doi: 10.1006/viro.1993.1210. Virology. 1993. PMID: 8460500
3,498 results
Jump to page
Feedback